Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of June 14, 2021, it operated 140 hospitals, 250 home health locations, and 93 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
IPO Year:
Exchange: NYSE
Website: encompasshealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $115.00 | Overweight | KeyBanc Capital Markets |
| 7/10/2024 | $100.00 | Outperform | Leerink Partners |
| 3/6/2024 | $95.00 | Overweight | Barclays |
| 3/14/2023 | $57.00 | Equal Weight | Barclays |
| 2/7/2022 | $90.00 → $80.00 | Strong Buy | Raymond James |
| 11/3/2021 | $94.00 → $80.00 | Buy | Mizuho |
| 11/2/2021 | $107.00 → $90.00 | Strong Buy | Raymond James |
| 10/13/2021 | $100.00 → $88.00 | Buy | Truist Securities |
| 9/24/2021 | $98.00 | Buy | UBS |
| 8/2/2021 | $95.00 → $107.00 | Outperform → Strong Buy | Raymond James |
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
10-Q - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
10-Q - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
8-K - Encompass Health Corp (0000785161) (Filer)
ARS - Encompass Health Corp (0000785161) (Filer)
DEF 14A - Encompass Health Corp (0000785161) (Filer)
The 61-bed inpatient rehabilitation hospital is Encompass Health's first hospital fully constructed using prefabricated modules. BIRMINGHAM, Ala., and HOUSTON, Nov. 11, 2024 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Houston at The Medical Center in Texas. The 61-bed inpatient rehabilitation hospital, located at 3010 Yellowstone Blvd., is Encompass Health's first hospital fully constructed using prefabricated modules. This innovative construction method, pursued in collaboration with Alabama-based company, BLOX, resulted in enhanced quality control
BIRMINGHAM, Ala. and WESLEY CHAPEL, Fla., Nov. 4, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in the master planned community of Wiregrass Ranch in Wesley Chapel, Florida. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupa
BIRMINGHAM, Ala., Oct. 22, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be November 21, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Company expects to record an approximate $0.2 million loss on early extinguishment of debt in the fourth quarter of 2024.
BIRMINGHAM, Ala., Oct. 17, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Jan. 15, 2025, to holders of record on Jan. 2, 2025. About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 165 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recover
BIRMINGHAM, Ala., Oct. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept. 30, 2024, after the market closes on Monday, Oct. 28, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Oct. 29, 2024, to discuss its results. The conference call may be accessed by dialing 800-343-4849 and giving the conference ID EHCQ324. International callers should dial 203-518-9848 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensur
The 39-bed inpatient rehabilitation hospital is Encompass Health's 165th hospital. BIRMINGHAM, Ala. and FORT MILL, S.C., Sept. 24, 2024 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation of Fort Mill in South Carolina. The 39-bed inpatient rehabilitation hospital, located at 2260 Vista Road, is Encompass Health's 165th hospital nationwide and its ninth hospital in South Carolina. Encompass Health Rehabilitation Hospital of Fort Mill provides essential
BIRMINGHAM, Ala., and JOHNSTON, R.I., July 30, 2024 /PRNewswire/ -- Today, Encompass Health (NYSE:EHC), the nation's largest owner and operator of rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Johnston, a 50-bed inpatient rehabilitation hospital located at 2109 Hartford Avenue in Johnston, Rhode Island. The hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients re
BIRMINGHAM, Ala., July 24, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of approximately 13% and declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Oct. 15, 2024, to holders of record on Oct. 1, 2024. Encompass Health also announced its board approved resetting the aggregate common stock repurchase authorization to $500 million. The Company repurchased approximately $17 million of its common stock during the second quarter and had ap
BIRMINGHAM, Ala., July 15, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today issued notice for redemption of $150 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be August 15, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Company expects to record an approximate $0.4 million loss on early extinguishment of debt in the third quarter of 2024.
BIRMINGHAM, Ala., July 11, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its second quarter ended June 30, 2024, after the market closes Monday, Aug. 5, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Aug. 6, 2024, to discuss its results. The conference call may be accessed by dialing 800-579-2543 and entering the conference ID EHCQ224. International callers should dial 785-424-1699 and provide the same conference ID. Please call approximately 10 minutes before the start of the call to ensure
4 - Encompass Health Corp (0000785161) (Issuer)
KeyBanc Capital Markets initiated coverage of Encompass Health with a rating of Overweight and set a new price target of $115.00
Leerink Partners initiated coverage of Encompass Health with a rating of Outperform and set a new price target of $100.00
Barclays initiated coverage of Encompass Health with a rating of Overweight and set a new price target of $95.00
Barclays initiated coverage of Encompass Health with a rating of Equal Weight and set a new price target of $57.00
Raymond James reiterated coverage of Encompass Health with a rating of Strong Buy and set a new price target of $80.00 from $90.00 previously
Mizuho reiterated coverage of Encompass Health with a rating of Buy and set a new price target of $80.00 from $94.00 previously
Raymond James reiterated coverage of Encompass Health with a rating of Strong Buy and set a new price target of $90.00 from $107.00 previously
Truist Securities reiterated coverage of Encompass Health with a rating of Buy and set a new price target of $88.00 from $100.00 previously
UBS initiated coverage of Encompass Health with a rating of Buy and set a new price target of $98.00
Raymond James upgraded Encompass Health from Outperform to Strong Buy and set a new price target of $107.00 from $95.00 previously
BIRMINGHAM, Ala., Oct. 17, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Jan. 15, 2025, to holders of record on Jan. 2, 2025. About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 165 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recover
BIRMINGHAM, Ala., Oct. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept. 30, 2024, after the market closes on Monday, Oct. 28, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Oct. 29, 2024, to discuss its results. The conference call may be accessed by dialing 800-343-4849 and giving the conference ID EHCQ324. International callers should dial 203-518-9848 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensur
BIRMINGHAM, Ala., July 24, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of approximately 13% and declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Oct. 15, 2024, to holders of record on Oct. 1, 2024. Encompass Health also announced its board approved resetting the aggregate common stock repurchase authorization to $500 million. The Company repurchased approximately $17 million of its common stock during the second quarter and had ap
BIRMINGHAM, Ala., July 11, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its second quarter ended June 30, 2024, after the market closes Monday, Aug. 5, 2024. The Company will host an investor conference call at 10 a.m. ET on Tuesday, Aug. 6, 2024, to discuss its results. The conference call may be accessed by dialing 800-579-2543 and entering the conference ID EHCQ224. International callers should dial 785-424-1699 and provide the same conference ID. Please call approximately 10 minutes before the start of the call to ensure
BIRMINGHAM, Ala., May 2, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on July 15, 2024, to holders of record on July 1, 2024. About Encompass Health Encompass Health (NYSE:EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 160 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recoverin
BIRMINGHAM, Ala., April 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its first quarter ended March 31, 2024, after the market closes Wednesday, April 24, 2024. The Company will host an investor conference call at 10 a.m. ET on April 25, 2024, to discuss its results. The conference call may be accessed by dialing 800-579-2543 and giving the conference ID EHCQ124. International callers should dial 785-424-1699 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you a
BIRMINGHAM, Ala., Feb. 28, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on April 15, 2024, to holders of record on April 1, 2024. About Encompass Health Encompass Health (NYSE:EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 161 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recov
BIRMINGHAM, Ala., Jan. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2023, after the market closes on Feb. 7, 2024. The Company will host an investor conference call at 10 a.m. ET on Feb. 8, 2024, to discuss its results. The conference call may be accessed by dialing 800-579-2543 and giving the conference ID EHCQ423. International callers should dial 785-424-1789 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you are connected.
BIRMINGHAM, Ala., Oct. 6, 2023 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its third quarter ended Sept. 30, 2023, after the market closes on Oct. 26, 2023. The Company will host an investor conference call at 10 a.m. ET on Oct. 27, 2023, to discuss its results. The conference call may be accessed by dialing 800-267-6316 and giving the conference ID EHCQ323. International callers should dial 203-518-9765 and give the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you are connected
BIRMINGHAM, Ala., July 20, 2023 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on October 16, 2023, to holders of record on October 2, 2023. About Encompass Health Encompass Health (NYSE:EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 158 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients r
Encompass Health (NYSE:EHC) has outperformed the market over the past 15 years by 2.14% on an annualized basis producing an average annual return of 14.69%. Currently, Encompass Health has a market capitalization of $8.61 billion. Buying $1000 In EHC: If an investor had bought $1000 of EHC stock 15 years ago, it would be worth $7,855.48 today based on a price of $85.49 for EHC at the time of writing. Encompass Health's Performance Over Last 15 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated co
Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $95 to $100.
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $108 to $113.
In the last three months, 6 analysts have published ratings on Encompass Health (NYSE:EHC), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 2 0 0 0 3M Ago 2 1 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $97.83, a high estimate of $108.00, and a low estimate of $94.00. Witnessing a positive shift, the current ave
Leerink Partners analyst Whit Mayo initiates coverage on Encompass Health (NYSE:EHC) with a Outperform rating and announces Price Target of $100.
The 70-bed inpatient rehabilitation hospital, located at 1355 Independence Drive, was purchased by Encompass Health in 2013.
Encompass Health's (NYSE:EHC) short percent of float has risen 8.65% since its last report. The company recently reported that it has 1.79 million shares sold short, which is 2.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.27 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interes
Stephens & Co. analyst Scott Fidel reiterates Encompass Health (NYSE:EHC) with a Overweight and maintains $94 price target.
GAINERS: 1933 Industries (OTC:TGIFF) shares closed up 31.87% at $0.01 CV Sciences (OTC:CVSI) shares closed up 17.65% at $0.08 Eastside Distilling (NASDAQ:EAST) shares closed up 9.80% at $1.04 Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 9.42% at $46.83 Cara Therapeutics (NASDAQ:CARA) shares closed up 7.96% at $0.68 Emeren Group (NYSE:SOL) shares closed up 6.43% at $1.74 Mexco Energy (AMEX:MXC) shares closed up 6.19% at $12.35 Psychemedics (NASDAQ:PMD) shares closed up 5.00% at $2.38 CNBX Pharmaceuticals (OTC:CNBX) shares closed up 4.44% at $0.01 CLS Holdings USA (OTC:CLSH) shares closed up 4.20% at $0.05 LOSERS: Item 9 Labs (OTC:INLB) shares closed down 99.00% at $1e-06 Heritage
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
BIRMINGHAM, Ala., and JOHNSTON, R.I., July 30, 2024 /PRNewswire/ -- Today, Encompass Health (NYSE:EHC), the nation's largest owner and operator of rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Johnston, a 50-bed inpatient rehabilitation hospital located at 2109 Hartford Avenue in Johnston, Rhode Island. The hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients re
BIRMINGHAM, Ala., Nov. 27, 2023 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced the appointment of Edward M. Christie III to its board of directors. This appointment will expand the Encompass Health board to 12 director seats as part of its ongoing succession planning. Christie joins the Encompass Health board with significant experience in finance, strategic and public company leadership, operations, and governmental regulation. Christie currently serves as President and Chief Executive Officer of Spirit Airlines, Inc., a leading ultra low-cost carrier
Announces retirement of five directors BIRMINGHAM, Ala., March 31, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced the appointment of Kevin J. O'Connor to the Encompass Health Board of Directors. In addition, for some time, its Nominating/Corporate Governance Committee has been focused on crafting an orderly and gradual plan for director succession and refreshment. In connection with Encompass Health's previously announced Board refreshment process, the Company announced that five directors, Yvonne M. Curl, Charles M. Elson, Leo I. Higdon, Jr., Joh
BIRMINGHAM, Ala., Sept. 7, 2021 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced the appointment of Christopher R. Reidy to the Encompass Health board of directors, effective October 1, 2021. This appointment will expand the Encompass Health board to 15 director seats as part of its ongoing succession planning. Mr. Reidy joins the Encompass Health board with significant experience in healthcare, finance, accounting, strategic planning, and information technology and security. Mr. Reidy currently serves as Executive Vice President, Chief Financial Offic
BIRMINGHAM, Ala., Aug. 24, 2021 /PRNewswire/ -- Encompass Health (NYSE:EHC), a national leader in integrated healthcare services, has named Mark Miller as its senior vice president of investor relations and strategic planning, effective Sept. 7, 2021. Miller has 20 years of healthcare investment leadership experience. He joins Encompass Health from Maximus where he serves as vice president of future market development, helping to guide strategy for its U.S. Services segment. In addition, he has previously served as both a buy-side and sell-side healthcare analyst. "We are del
BIRMINGHAM, Ala., June 21, 2021 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that Barbara A. Jacobsmeyer, President, Inpatient Hospitals, has been appointed as Chief Executive Officer of Home Health and Hospice, effective immediately. She succeeds April K. Anthony, whose previously announced departure was effective on June 18, 2021. "Barb is a proven leader with extensive healthcare operating experience," said Mark J. Tarr, President and Chief Executive Officer of Encompass Health. "Supported by an award-winning culture and innovative technologies, the ho